However, no statistically difference was found between the two groups in age of onset, risk factors, the proportion of elevated serum NT‐proBNP, the proportion of sLAE and left ventricular hypertrophy, the proportion of MACI, the mRS score on day 14, and the rate of deep venous thrombosis. This evidence concerns the gene NPPB and left ventricular hypertrophy.